CYP19A1 and endometrial cancer: Furthermore, the ten CYP19A1 SNPs genotyped have been reported to influence hormone estradiol levels in postmenopausal women [13,24], predict clinical outcome in metastatic breast cancer patients treated with letrozole [25], and significantly increase risk of colon [26] and endometrial cancer development [13,24].